November - 2022

Common chemotherapy drug could carry toxic inheritance for future generations of cancer survivors

A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington ...

Data Support Whole Brain Irradiation Reduction in Pediatric Cancer Survivors

Results from a pooled case control study indicate that meninges are very radiosensitive in pediatric patients who were treated at prior ...

Diet High in Sugar May Accelerate Aging in Survivors of Childhood Cancer

High sugar consumption may increase age-related health conditions in survivors of childhood cancer, explained study authors at the AACR ...

World-first clinical trial in ‘man’s best friend’ could unlock breakthrough for kids with cancer

Telethon Kids Institute is leading a unique clinical trial in pet dogs that could pave the way for a new immunotherapy treatment for one...

Altered cell behavior behind resistance in neuroblastoma

Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to...

McMaster University researchers pinpoint potential treatment for lethal childhood cancer

An enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster ...

Chronic Conditions More Likely Among Survivors of Pediatric Wilms Tumor

Survivors of Wilms tumor are more likely than the general population to experience chronic health conditions, according to a study...

Changes to chromosomes impact how children’s brain tumours respond to treatment

Every year in the UK, around 55 children are diagnosed with medulloblastoma, and there is a pressing need for new treatments. Now, led...

‘Chameleon cancers’ change colors to evade treatment, study reveals

Scientists from the Princess Máxima Center for Pediatric Oncology have discovered that some leukemias are capable of altering their...

Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse

Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination. Read...

1

Pediatric Cancer Survivors Treated With Abdominopelvic RT Have Higher Risk of CRC

Study shows potential of new treatment strategies for most common childhood cancer

Promising target for CAR T cells helps cancer trick the immune system

Palliative Care Important for Young Patients During ‘Identity Development’

Scientists discover new Achilles heel of leukemia cells

Promising investigational therapy improves survival in aggressive childhood brain tumor

Childhood cancer mortality has fallen significantly in the US, but disparities have emerged

St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing

Analysis shows high rate of ‘significant’ health problems in childhood cancer survivors

Fusion oncoprotein forces cell fates toward rhabdomyosarcoma